March 25, 2026 · Form 4 insider transaction
Raben David bought 5,500 shares of BICARA THERAPEUTICS INC at $3.79 per share, a transaction worth $20.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.